Skip to main content

Table 1 Comparison of patients' characteristics differentiated to the type of schedule

From: A non-randomised, single-centre comparison of induction chemotherapy followed by radiochemotherapy versus concomitant chemotherapy with hyperfractionated radiotherapy in inoperable head and neck carcinomas

 

SEQ (sequential, n = 70)

CON (concomitant, n = 52)

p

Parameter

number

(%)

number

(%)

0.80

Age, years

     

Mean (Range)

53 (37–77)

 

52.8 (39–66)

 

0.79

Performance status (WHO)

    

0.67

0,1

35

(50)

30

(58)

 

2,3

27

(39)

19

(37)

 

Unknown

8

(11)

2

(4)

 

T-stage (UICC)

    

0.54

T2

4

(6)

3

(6)

 

T3

18

(26)

9

(17)

 

T4

48

(68)

40

(77)

 

N-stage

    

0.13

N2c

23

(33)

15

(29)

 

N3

8

(11)

7

(14)

 

RTOG stage groupings

    

0.58

III (T3-4 N0, T1-2 N2)

5

(7)

1

(2)

 

IV (T1-2 N3, T3 N1-2, T4 N1)

23

(33)

16

(31)

 

V (T4 N2-3)

41

(59)

35

(67)

 

UICC stage groupings

     

IV (a + b)

69

(99)

52

(100)

 

Tumor location

    

0.19

Oral cavity

7

(10)

10

(19)

 

Oropharynx

38

(54)

30

(58)

 

Hypopharynx, Larynx

25

(36)

12

(23)

 

Mean tumor size (cm)

4.8

 

4.6

 

0.46

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us